Clemastine

Role

Indications

Reactions

Secondary

Product Used For Unknown Indication	43.7%
Drug Abuse	42.8%
Retroperitoneal Abscess	1.9%
Prophylactic Chemotherapy	1.5%
Breast Cancer Metastatic	1.1%
Hypertension	1.1%
Prophylaxis	1.1%
B-cell Lymphoma	0.9%
Bacterial Infection	0.8%
Hypersensitivity	0.8%
Ovarian Cancer	0.8%
Chronic Sinusitis	0.6%
Dermatitis Contact	0.6%
Drug Use For Unknown Indication	0.6%
Premedication	0.6%
Anaphylactic Reaction	0.4%
Chronic Lymphocytic Leukaemia	0.4%
Prophylaxis Of Nausea And Vomiting	0.4%
Continuous Haemodiafiltration	0.2%

Large Intestine Perforation	14.3%
Surgery	14.3%
Drug Ineffective	7.1%
Dyspnoea	7.1%
Electrocardiogram Change	7.1%
Hypersensitivity	7.1%
Rash Erythematous	7.1%
Renal Failure	7.1%
Somnolence	7.1%
Thinking Abnormal	7.1%
Toxic Skin Eruption	7.1%
Ventricular Hypokinesia	7.1%

Concomitant

Premedication	20.7%
Prophylaxis	14.2%
Product Used For Unknown Indication	10.6%
Breast Cancer	10.5%
T-cell Lymphoma	8.2%
Diffuse Large B-cell Lymphoma	5.0%
Retroperitoneal Abscess	4.0%
B-cell Lymphoma	3.1%
Drug Use For Unknown Indication	3.0%
Non-small Cell Lung Cancer	2.8%
Nervous System Disorder	2.7%
Abscess	2.4%
Urticaria	2.1%
Hypersensitivity	2.0%
Ovarian Cancer	1.7%
Prophylaxis Of Nausea And Vomiting	1.6%
Mucopolysaccharidosis Ii	1.4%
Lymphadenopathy	1.3%
Musculoskeletal Pain	1.3%
Nausea	1.3%

Vomiting	12.9%
Conjunctivitis	9.4%
Lymphadenopathy	7.1%
Oxygen Saturation Decreased	7.1%
Pancytopenia	5.9%
Rash	5.9%
General Physical Health Deterioration	4.7%
Pneumonia	4.7%
Respiratory Failure	4.7%
Weight Decreased	4.7%
Xeroderma	4.7%
Bone Marrow Failure	3.5%
Gastric Haemorrhage	3.5%
Multi-organ Failure	3.5%
Pyrexia	3.5%
Tremor	3.5%
Visual Impairment	3.5%
Acute Pulmonary Oedema	2.4%
Atelectasis	2.4%
Blood Creatinine Increased	2.4%